OLFM4
Olfactomedin-4
Also known as: GC1, GW112, OlfD, OLFM4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6UX06
- Gene
- OLFM4
- Ensembl
- ENSG00000102837
- Chromosome
- 13
- Canonical length
- 510 aa
- Protein class
- Predicted secreted proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol
- Secretome location
- Secreted to digestive system
- Quaternary structure
- Homomultimer
OverviewNCBI Gene
This gene was originally cloned from human myeloblasts and found to be selectively expressed in inflammed colonic epithelium. This gene encodes a member of the olfactomedin family. The encoded protein is an antiapoptotic factor that promotes tumor growth and is an extracellular matrix glycoprotein that facilitates cell adhesion. [provided by RefSeq, Mar 2011]
Canonical amino-acid sequenceUniProt
510 residues, UniProt reviewed canonical sequence.
>Q6UX06|OLFM4
1 MRPGLSFLLA LLFFLGQAAG DLGDVGPPIP SPGFSSFPGV DSSSSFSSSS RSGSSSSRSL
61 GSGGSVSQLF SNFTGSVDDR GTCQCSVSLP DTTFPVDRVE RLEFTAHVLS QKFEKELSKV
121 REYVQLISVY EKKLLNLTVR IDIMEKDTIS YTELDFELIK VEVKEMEKLV IQLKESFGGS
181 SEIVDQLEVE IRNMTLLVEK LETLDKNNVL AIRREIVALK TKLKECEASK DQNTPVVHPP
241 PTPGSCGHGG VVNISKPSVV QLNWRGFSYL YGAWGRDYSP QHPNKGLYWV APLNTDGRLL
301 EYYRLYNTLD DLLLYINARE LRITYGQGSG TAVYNNNMYV NMYNTGNIAR VNLTTNTIAV
361 TQTLPNAAYN NRFSYANVAW QDIDFAVDEN GLWVIYSTEA STGNMVISKL NDTTLQVLNT
421 WYTKQYKPSA SNAFMVCGVL YATRTMNTRT EEIFYYYDTN TGKEGKLDIV MHKMQEKVQS
481 INYNPFDQKL YVYNDGYLLN YDLSVLQKPQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OLFM4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 1,220 nTPM
Expression across tissuesHPA
Tissue
- small intestine: 1,220 nTPM
- duodenum: 1,141 nTPM
- pancreas: 666 nTPM
- rectum: 533 nTPM
- colon: 423 nTPM
- vagina: 265 nTPM
Single-cell type
- paneth cells: 6,606 nCPM
- prostatic club cells: 5,606 nCPM
- enteric stem cells: 3,771 nCPM
- neutrophil progenitors: 3,094 nCPM
- gastric progenitor cells: 1,997 nCPM
- enteric transient amplifying cells: 1,900 nCPM
Immune cell
- neutrophil: 0.1 nTPM
- total PBMC: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- basal ganglia: 0.9 nTPM
- cerebral cortex: 0.9 nTPM
- hypothalamus: 0.7 nTPM
- amygdala: 0.4 nTPM
- midbrain: 0.4 nTPM
- spinal cord: 0.4 nTPM
ReferencesPubMed · IEDB
Publications for OLFM4 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
2 publications
- Olfactomedin-4 autoantibodies give unusual c-ANCA staining patterns with reactivity to a subpopulation of neutrophils.
2015 · J Leukoc Biol · RCR 0.6 · 21 citations - Determination of Subset-Restricted Anti-neutrophil Cytoplasmic Antibodies (ANCA) by Immunofluorescence Cytochemistry.
2019 · Methods Mol Biol · RCR 0.1 · 2 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.1
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.34
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell adhesion
- immune response
- negative regulation of canonical NF-kappaB signal transduction
- negative regulation of immune response
- positive regulation of substrate adhesion-dependent cell spreading
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of OLFM4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OLFM4 as an antibody target. Whether an autoantibody or antibody against OLFM4 could matter depends on whether native OLFM4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OLFM4 is annotated at the cell surface, where native OLFM4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label OLFM4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...